Loading...
The URL can be used to link to this page
Your browser does not support the video tag.
Home
My WebLink
About
102424 - Experts propose network dedicated to immunocompromised patients
ALERT: BE CAUTIOUS This email originated outside the organization. Do not open attachments or click on links if you are not expecting them. ImmunOptimize workshop | Cancer AI Alliance launches | Lobular breast cancer symposium View as Web page <https://secure.fredhutch.org/site/R?i=2UBsVWNxeIHL4tfIpDFGR1XlmEKv8Abj5bZJd6Qnfw33YEPQiccEEQ> <https://secure.fredhutch.org/site/R?i=afRlJt-K3s8jTk31Xb9U_CCn3h0enIgNszexCVBNTO3F9AOyGML1pQ> <https://secure.fredhutch.org/images/content/pagebuilder/fhcc-eml-hdr-shadow.png> <https://secure.fredhutch.org/images/content/pagebuilder/hdr-eml-hutch-news-fhcc.jpg> October 24, 2024 ⋅ A monthly digest of the latest from Fred Hutch ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease network <https://secure.fredhutch.org/site/R?i=VroJ5gn87Ccuf3mhX_KqBH_M4bLvICxeIyfyn55IxJbXk-wnQ9e1mQ> The COVID-19 pandemic made plain what many patients, clinicians and researchers have known for decades: people with weakened immune systems are much more vulnerable to infectious diseases. But immunocompromised patients are usually left out of large clinical trials that assess new treatments and vaccines, leaving a data gap that hampers clinical care. In September, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop to brainstorm strategies to address the unmet needs of immunocompromised patients. “We need roots, not parachutes,” said Fred Hutch Cancer Center infectious disease expert Joshua Hill, MD, who headed the ImmunOptimize scientific committee. “We need a grassroots effort to address the unmet needs of immunocompromised patients. The time is right to bring the conversations to the forefront.” At the workshop, stakeholders from academia, industry and government, including the U.S. Food and Drug Administration and the National Institutes of Health discussed how to bridge the data gap that leaves immunocompromised patients and their clinicians unable to make evidence-based treatment decisions. Read about ImmunOptimize <https://secure.fredhutch.org/site/R?i=gi4Ki12bXhUeZn 2a0GLBzrVvJQMoAgxNxGrhj9FyPhqENF8Cna2CKQ> . ________________________________ Fred Hutch expands research capacity <https://secure.fredhutch.org/site/R?i=-Wf4kOJZ3cY2zbFBJdqxXXUzlpMO78WiUReTqDNLIhYQoygONBdyuQ> Photo by Robert Hood / Fred Hutch News Service Fred Hutch is expanding its research footprint <https://secure.fredhutch.org/site/R?i=lpmVTm3gGar-zAC1LPF1hCszigiIw2M24v-v7YF0lo5IKVqSjJy7EQ> in South Lake Union with three buildings on Eastlake Avenue East that will add more than 300,000 square feet devoted to labs and flexible spaces. ________________________________ The Latest Cancer AI Alliance to unlock discoveries, transform care <https://secure.fredhutch.org/site/R?i=DcnN1VMLjCLoaNGNkQUYgZ-NlMjm-drFcAq-22R6dd1ehHA-Snvv7Q> Four National Cancer Institute-designated cancer centers — Dana-Farber Cancer Institute, Fred Hutch Cancer Center, Memorial Sloan Kettering Cancer Center, and The Sidney Kimmel Comprehensive Cancer Center and Whiting School of Engineering at Johns Hopkins — have joined forces and secured funding from AI technology leaders AWS, Deloitte, Microsoft and NVIDIA, to create the Cancer AI Alliance (CAIA). The alliance will apply responsible AI to the collective power of the participating cancer centers’ data to unlock insights while protecting data security, all to identify more ways to transform cancer research and care. Symposium shines a light on long-overlooked lobular <https://secure.fredhutch.org/site/R?i=vsipi8O19XOKWEOoPwHK4avz-rXX2O6refbQLag5jfyD4p_F-FsFkw> Lobular breast cancer — the second-most common type of breast cancer — has finally made its way into the research spotlight. Scientists are filling in the research gaps and awareness is growing, thanks in large part to efforts by patients, pathologists, clinicians and others around the world, many of whom gathered for the 2024 International Invasive Lobular Carcinoma Symposium, held in September. Making the most of a small supply <https://secure.fredhutch.org/site/R?i=eofr6iV0VAL_V9BdReFyQ_Wh9MFVoD5iIp-p1P5n3l78eKDkf4fdog> Fred Hutch researchers received a $1.3 million grant from the U.S. Department of Defense to study the fundamental biology of five rare liver cancers that could lead to new treatments one day. Atlas of Inspiring Hispanic/Latinx Scientists launches <https://secure.fredhutch.org/site/R?i=x_BOPblIUzNNhmmUrqvewZqdhHSArMKyd2cx2QqTxuhwmp0O_svzDA> Tired of wondering why conference speaker panels are not more diverse, Christina Termini, PhD, MM, decided to do something about it, creating the Atlas of Inspiring Hispanic/Latinx Scientists, an online compendium of nearly 400 Hispanic and Latinx scientists that is now part of Fred Hutch’s website. Bottleneck breakthrough on AIDS cause <https://secure.fredhutch.org/site/R?i=HRZEB_BQ-X-RZro7OWQYHnxeZ3Na1mKPnXw9KeF-xwnySetGvEj2Nw> Fred Hutch researchers discovered why some HIV-1 variants are more transmissible than others, which could generate new approaches to stop the virus that causes AIDS at cell entry. Engineered HSV can trigger genetic chain reaction, rejigger genes <https://secure.fredhutch.org/site/R?i=uIvteKnE24j4GFOuMpgjvypU9ulBa5RjW5iDcmCSgq_f4mp0YpvOXg> A proof-of-concept study by Fred Hutch researchers, which used a CRISPR gene editing tool to change the color of fluorescent viruses, potentially opens the door to a treatment that uses HSV-based gene therapy to cure HSV. ________________________________ Good News Angela Broughton honored with T. Evans Wyckoff Award <https://secure.fredhutch.org/site/R?i=nwv_NVVTp8jb0xxhRnCF8vDUmS9pbfCKJW8rf53s5h6Q66Wi4kEsAw> After a three-year hiatus, the T. Evans Wyckoff Award is back at Fred Hutch. Angela Broughton, a pharmacy billing coordinator on the retail pharmacy team was recently announced as this year’s recipient. ________________________________ Check out our Legacy Toolkit! National Estate Planning Awareness Week is October 21-27 — a reminder to plan ahead to protect your loved ones and the causes you care about by creating or updating your estate plan. When you include Fred Hutch in your estate plan, you will leave a legacy of fueling life-changing discoveries for generations to come. Visit our Legacy Toolkit for more information. <https://secure.fredhutch.org/site/R?i=pEo1q-8dn_AoegHiwhM2zxjBY58tV3WEufMRz9rHIrAI643Ig9Ypog> ________________________________ Share this newsletter with family or friends <https://secure.fredhutch.org/site/R?i=J_YNG4QVvfHml7Tmhdy2FICZgYA_QP6vcvghrhFg8T0aOMdoaC3fVA> <https://secure.fredhutch.org/site/R?i=DZfm2sjUh9XrzR9WofBa90dwVn6kVNpMz1UDwxV35p25h9FiH1JsZQ> 1100 Fairview Ave. N., Seattle, WA 98109 communications@fredhutch.org <mailto:communications@fredhutch.org> 206.667.5000 <https://secure.fredhutch.org/site/R?i=YEqdJD0kxYs3kpJHvE1NXIP1yf32OvYbbcn1omjGNVk-_jDQ5HtlDg> <https://secure.fredhutch.org/site/R?i=sAc1axSW6z2JEdspsFyCUWo_shau6qFijd06srA0YpXqkd7zLho_Sg> <https://secure.fredhutch.org/site/R?i=cf__8Q9FUts42tgTdfirKBmOWIUg3MjgOnvpquCPNn7NmAk-psvl3g> <https://secure.fredhutch.org/site/R?i=lmzT35-7G2mKDNBM6lRe4qY82P9R3GN2tDQsEpB0gjWJwtJn_Fhrmw> ________________________________ Unsubscribe <http://engage.fredhutch.org/site/CO?i=eyF02OStsyzeOC-feYDlZtXXCOzcq7XR7fQdU1RghfUvKVzt-l3ey_ANC2LffHCm&cid=1021> from Fred Hutch emails or contact us at optout@fredhutch.org <mailto:optout@fredhutch.org> to be removed from our mailing list. Fred Hutchinson Cancer Center is a 501(c)(3) nonprofit organization. For information about our privacy practices, see our Privacy Policy <https://secure.fredhutch.org/site/R?i=bNrlq7F7ABE9w5ZM3-s_tT2c8p5Eu9tomrTWOQ1ZQLQPWDpxmXjDBQ> . © 2024 Fred Hutchinson Cancer Center. All rights reserved. <http://engage.fredhutch.org/site/PixelServer?j=a3a3hCsLahmNtRfnBBzI7Ae048wv94NRUmbxOj3LdRNe40cWjnol1w> ecure.fredhutch.org/site/R?i=bNrlq7F7ABE9w5ZM3-s_tT2c8p5Eu9tomrTWOQ1ZQLQPWDpxmXjDBQ","url/anchorText":"Privacy Policy","url/urlTextSpan":{"beginIndex":23146,"length":14},"@EntityId":"d6bf2292-21de-4d d4-ab86-9551bf08c65a","@extractionTimeUtc":"2024-10-24T22:53:43.2191320\u002B00:00"}]